Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands.
Tetrapeptide derived major histocompatability (MHC) II ligands have been developed that contain no unadulterated peptide bonds. These are the 'least peptidic' ligands for any MHC protein yet reported.